• Parul Sharma
• Chandani Kumari
• Kritigya Sharma

t Inflammation of the joints causes arthritis. Arthritis causes pain, swelling, stiffness and loss of motion and most common arthritis in children is known as juvenile idiopathic arthritis (JIA). Juvenile idiopathic arthritis is heterogenous group of disease of uncertain origin characterized by arthritis that develops before the age of 16 years. It is the most common childhood chronic rheumatic disease and cause much disability. Juvenile idiopathic arthritis is considered as a multifactorial genetic and environmental risk factors. Juvenile arthritis is a rheumatic disease which causes loss of function due to an inflamed supporting structure. According to demographic characteristics, clinical features, treatment features, treatment modalities and disease prognosis, the disease is divided into many groups. Systemic juvenile arthritis which is characterized by recurrent fever and rash. Oligo juvenile idiopathic arthritis, which is common among young females patients. Then comes the seropositive polyarticular juvenile arthritis which is seen in less than 10% pediatric patients. New research of the disease pathogenesis is the basis for the development of new and better treatments for JIA. The goal of such treatments is not just to relieve pain, but also to control inflammation and stop irreversible joint damage and long-term disability. Biological agents have significantly improved the disease prognosis.

Juvenile arthritis, methotrexate, osteoporosis, joint pain

"JUVENILE IDIOPATHIC ARTHRITIS: A REVIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 5, page no.f411-f419, May-2021, Available :http://www.jetir.org/papers/JETIR2105721.pdf

"JUVENILE IDIOPATHIC ARTHRITIS: A REVIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 5, page no. ppf411-f419, May-2021, Available at : http://www.jetir.org/papers/JETIR2105721.pdf